The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis
Public ClinicalTrials.gov record NCT03210259. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
VOLTAIRE-X: Pharmacokinetics, Safety, Immunogenicity and Efficacy of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis: a Randomized, Double-blind, Parallel-arm, Multiple-dose, Active Comparator Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the trial is to assess the PK similarity between patients receiving Humira® continuously vs those who alternate between BI 695501 and Humira®, in patients with moderate-to-severe chronic plaque psoriasis. The secondary objectives of this trial are to descriptively compare the safety, immunogenicity and efficacy profiles between patients receiving Humira® continuously vs those who alternate between BI 695501 and Humira®.
Study identification
- NCT ID
- NCT03210259
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 259 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 10, 2017 (Actual)
- Primary completion
- Apr 16, 2019 (Actual)
- Completion
- Apr 16, 2019 (Actual)
- Last update posted
- Jul 14, 2021
2017 – 2019
United States locations
- U.S. sites
- 21
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center, PC | Birmingham | Alabama | 35205 | — |
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Shahram Jacobs MD, Inc./Unison Clinical Trials | Sherman Oaks | California | 91403 | — |
| Universal Clinical Research | Hialeah | Florida | 33012 | — |
| New Horizon Research Center | Miami | Florida | 33175 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| Kansas City Dermatology, PA | Overland Park | Kansas | 66215 | — |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Palmetto Clinical Trial Services, LLC | Fountain Inn | South Carolina | 29681 | — |
| Arlington Research Center | Arlington | Texas | 76011 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| MultiCare Institute for Research and Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03210259, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2021 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03210259 live on ClinicalTrials.gov.